"I want patients to understand their options and have choices."
- Ann H. Partridge, MD, MPH
"We need to tailor therapies better for individual patients….the problem is that we overtreat the many to benefit the few."
- Lawrence J. Solin, MD
"There is risk both with treatment and with treatment deescalation, and we need to be able to quantify that trade off in a much better way for an individual patient."
- Shelley Hwang, MD, MPH
"The next few years will witness the publication of major trial results and potentially chart a new course of DCIS management."
- Lars J. Grimm, MD, MHS
For many women diagnosed with DCIS, one of the toughest questions is whether surgery is truly necessary — especially if the DCIS looks low-risk. The idea of active monitoring (close follow-up with imaging and exams, without immediate surgery) is gaining attention in clinical trials. But one challenge remains: how can doctors be sure a biopsy really shows the whole truth about the DCIS?
